Virtual Tumor Board: Neoadjuvant for Stage III NSCLC

In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the role of neoadjuvant therapy for stage III NSCLC using a virtual tumor board format. This area has become increasingly complex of late, as clinicians have seen several large studies report encouraging results with peri-operative immunotherapy and targeted therapy.